151 related articles for article (PubMed ID: 16542690)
1. The Partec CyFlow Counter could provide an option for CD4+ T-cell monitoring in the context of scaling-up antiretroviral treatment at the district level in Malawi.
Fryland M; Chaillet P; Zachariah R; Barnaba A; Bonte L; Andereassen R; Charrondière S; Teck R; Didakus O
Trans R Soc Trop Med Hyg; 2006 Oct; 100(10):980-5. PubMed ID: 16542690
[TBL] [Abstract][Full Text] [Related]
2. Using BD Vacutainer CD4 Stabilization Tubes for Absolute Cluster of Differentiation Type 4 Cell Count Measurement on BD FacsCount and Partec Cyflow Cytometers: A Method Comparison Study from Zimbabwe.
Vogt F; Van den Bergh R; Bernasconi A; Moyo B; Havazvidi L; Bastard M; Flevaud L; Taziwa F; Makondo E; Mtapuri-Zinyowera S
PLoS One; 2015; 10(8):e0136537. PubMed ID: 26295802
[TBL] [Abstract][Full Text] [Related]
3. New BD FACSCount CD4 reagent system for simultaneous enumeration of percent and absolute CD4 T-lymphocytes in HIV-1-infected pediatric patients.
Pattanapanyasat K; Sukapirom K; Kowawisatsut L; Thepthai C
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S98-106. PubMed ID: 18307252
[TBL] [Abstract][Full Text] [Related]
4. Laboratory and field evaluation of the Partec CyFlow miniPOC for absolute and relative CD4 T-cell enumeration.
Wade D; Diaw PA; Daneau G; Diallo AA; Mboup S; Dieye TN; Kestens L
PLoS One; 2015; 10(2):e0116663. PubMed ID: 25688553
[TBL] [Abstract][Full Text] [Related]
5. Affordable flow cytometry for enumeration of absolute CD4+ T-lymphocytes to identify subtype C HIV-1 infected adults requiring antiretroviral therapy (ART) and monitoring response to ART in a resource-limited setting.
Zijenah LS; Kadzirange G; Madzime S; Borok M; Mudiwa C; Tobaiwa O; Mucheche M; Rusakaniko S; Katzenstein DA
J Transl Med; 2006 Aug; 4():33. PubMed ID: 16907973
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a single-platform microcapillary flow cytometer for enumeration of absolute CD4+ T-lymphocyte counts in HIV-1 infected Thai patients.
Pattanapanyasat K; Phuang-Ngern Y; Lerdwana S; Wasinrapee P; Sakulploy N; Noulsri E; Thepthai C; McNicholl JM
Cytometry B Clin Cytom; 2007 Sep; 72(5):387-96. PubMed ID: 17474130
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two alternative methods for CD4+ T-cell determination (Coulter manual CD4 count and CyFlow) against standard dual platform flow cytometry in Uganda.
Karcher H; Böhning D; Downing R; Mashate S; Harms G
Cytometry B Clin Cytom; 2006 May; 70(3):163-9. PubMed ID: 16498672
[TBL] [Abstract][Full Text] [Related]
8. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
9. Simplified volumetric flow cytometry allows feasible and accurate determination of CD4 T lymphocytes in immunodeficient patients worldwide.
Cassens U; Göhde W; Kuling G; Gröning A; Schlenke P; Lehman LG; Traoré Y; Servais J; Henin Y; Reichelt D; Greve B
Antivir Ther; 2004 Jun; 9(3):395-405. PubMed ID: 15259902
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in Zimbabwe.
Manasa J; Musabaike H; Masimirembwa C; Burke E; Luthy R; Mudzori J
Clin Vaccine Immunol; 2007 Mar; 14(3):293-8. PubMed ID: 17267593
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a flow cytometry method for CD4 T cell enumeration based on volumetric primary CD4 gating using thermoresistant reagents.
Dieye TN; Diaw PA; Daneau G; Wade D; Sylla Niang M; Camara M; Diallo AA; Toure Kane C; Diop Ndiaye H; Mbengue B; Dieye A; Kestens L; Mboup S
J Immunol Methods; 2011 Sep; 372(1-2):7-13. PubMed ID: 21835181
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new single-parameter volumetric flow cytometer (CyFlow(green)) for enumeration of absolute CD4+ T lymphocytes in human immunodeficiency virus type 1-infected Thai patients.
Pattanapanyasat K; Lerdwana S; Noulsri E; Chaowanachan T; Wasinrapee P; Sakulploy N; Pobkeeree V; Suksripanich O; Thanprasertsuk S; Spira TJ; Tappero JW; Levine WC
Clin Diagn Lab Immunol; 2005 Dec; 12(12):1416-24. PubMed ID: 16339065
[TBL] [Abstract][Full Text] [Related]
13. Targeting CD4 testing to a clinical subgroup of patients could limit unnecessary CD4 measurements, premature antiretroviral treatment and costs in Thyolo District, Malawi.
Zachariah R; Teck R; Ascurra O; Humblet P; Harries AD
Trans R Soc Trop Med Hyg; 2006 Jan; 100(1):24-31. PubMed ID: 16202436
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N
AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
17. Negative influence of age on CD4+ cell recovery after highly active antiretroviral therapy in naive HIV-1-infected patients with severe immunodeficiency.
Micheloud D; Berenguer J; Bellón JM; Miralles P; Cosin J; de Quiros JC; Conde MS; Muñoz-Fernández MA; Resino S
J Infect; 2008 Feb; 56(2):130-6. PubMed ID: 18192020
[TBL] [Abstract][Full Text] [Related]
18. Reliable and accurate CD4+ T cell count and percent by the portable flow cytometer CyFlow MiniPOC and "CD4 Easy Count Kit-Dry", as revealed by the comparison with the gold standard dual platform technology.
Nasi M; De Biasi S; Bianchini E; Gibellini L; Pinti M; Scacchetti T; Trenti T; Borghi V; Mussini C; Cossarizza A
PLoS One; 2015; 10(1):e0116848. PubMed ID: 25622041
[TBL] [Abstract][Full Text] [Related]
19. Patient retention and attrition on antiretroviral treatment at district level in rural Malawi.
Massaquoi M; Zachariah R; Manzi M; Pasulani O; Misindi D; Mwagomba B; Bauernfeind A; Harries AD
Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):594-600. PubMed ID: 19298993
[TBL] [Abstract][Full Text] [Related]
20. African regional external quality assessment for CD4 T-cell enumeration: development, outcomes, and performance of laboratories.
Glencross DK; Aggett HM; Stevens WS; Mandy F
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S69-79. PubMed ID: 18228560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
